Registry to Study Long-Term Safety and Effectiveness of Advanta VXT and Flixene Vascular Grafts for Peripheral Artery Repair or Replacement

What this Trial Is About

This research aims to assess the long-term safety and performance of two types of vascular grafts, Advanta VXT and Flixene, used for repairing or replacing peripheral arteries. The study focuses on patients who have undergone these surgical procedures and seeks to provide more information about how useful these grafts are in clinical practice. Participants in this registry have received either the Advanta VXT graft, which has two layers including a support layer and sometimes a ringed design, or the Flixene graft, which has three layers and does not require ring support. The study involves collecting data from the time of the surgery and continuing for at least three years afterward to monitor outcomes. During the study, researchers will review medical records and follow-up information for a minimum of three years after the procedure. They will measure the percentage of participants meeting safety and efficacy goals, monitor complications, and assess graft performance using clinical indicators such as the Rutherford Category and Ankle-Brachial Index. This long-term follow-up helps to understand how well these vascular grafts work and their safety in real-world use.

Advanta VXT and Flixene PMCF Registry